| |
| |
|
| Insider
Information: |
Kingsley Alfred D |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,968,356 |
|
|
Indirect Shares
|
1,512,809 |
|
|
| Direct
Value |
$5,137,134 |
|
|
|
Indirect Value
|
$1,323,637 |
|
|
| Total
Shares |
7,481,165 |
|
|
| Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
| Percentage
Gain/Loss : |
 -38.5%
|
 148.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-08-22 |
4 |
B |
$0.20 |
$17,902 |
D/D |
89,512 |
4,669,522 |
2.44 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-01-16 |
4 |
A |
$0.00 |
$0 |
I/I |
30,000 |
1,636,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
50,000 |
1,686,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
30,000 |
1,716,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
4,719,522 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
4,769,522 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
360,000 |
587,942 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
2,076,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-15 |
4 |
A |
$0.00 |
$0 |
I/I |
10,405 |
598,347 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,671 |
4,778,193 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(248,082) |
350,265 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-12-31 |
4/A |
D |
$0.00 |
$0 |
I/I |
(191,163) |
407,184 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,715 |
2,079,413 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,572 |
4,786,765 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,429 |
2,082,842 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
7,000 |
414,184 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2009-12-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,000 |
4,935,432 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,100 |
4,918,332 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-08-18 |
4 |
OE |
$1.82 |
$1,818,000 |
D/D |
1,000,000 |
5,918,332 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-10-21 |
4 |
OE |
$2.00 |
$894,008 |
D/D |
447,004 |
6,365,336 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-11-01 |
4 |
OE |
$2.00 |
$2,074,116 |
D/D |
1,037,058 |
7,402,394 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-12-01 |
5 |
A |
$0.00 |
$0 |
D/D |
100,000 |
7,502,394 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-07-30 |
4 |
D |
$4.77 |
$667,254 |
D/D |
(140,000) |
7,512,394 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-10-25 |
5 |
A |
$0.00 |
$0 |
D/D |
180,000 |
7,290,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-11-15 |
4 |
S |
$2.90 |
$1,000,001 |
D/D |
(344,828) |
7,167,566 |
0 |
- |
|
84 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
